Clinical Trials Logo

Wrist Osteoarthritis clinical trials

View clinical trials related to Wrist Osteoarthritis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06196528 Recruiting - Clinical trials for Wrist Osteoarthritis

WristArt Total Wrist Arthroplasty Implant First In Human Study

Start date: January 2, 2024
Phase: N/A
Study type: Interventional

The WristArt implant will be implanted for the first time in humans' wrists

NCT ID: NCT05499559 Recruiting - Hand Osteoarthritis Clinical Trials

Effects of 12-week Digital Treatment in Patients With Hand OA on Pain and Function

Start date: April 1, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate the effect of a 12 week digital treatment program for patients with hand osteoarthritis. The treatment consisted of exercises and educational sessions with respect to the disease, its natural course and recommended treatment strategies. Design: An observational longitudinal cohort study. The investigators will include participants who participated in the digital treatment of Joint Academy® for 3 months. Outcomes: Investigators will analyze pain with Numeric Rating Scale (NRS) 0-10 (best to worst), function with the Functional Index for Hand OsteoArthritis (FIHOA) and HRQL with EQ-5D-5L at baseline and at 3 months. Main outcome will be change in pain. The investigators will also analyze minimally clinical important changes (improved or not) and mean changes in EQ-5D-5L index score, pain and function.

NCT ID: NCT04260165 Recruiting - Clinical trials for Wrist Osteoarthritis

Proximal Row Carpectomy vs Four-corner Fusion for Osteoarthritis of the Wrist

PROOF
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Study purpose is to compare the outcome after proximal row carpectomy (PRC) vs four-corner fusion (FCA) for SLAC/SNAC II-III type osteoarthritis (OA) in a double-blinded randomized controlled study setting. Patients with radiologically and clinically confirmed OA are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo either PRC or FCA. The study will be patient and assessor blinded. Baseline data is collected preoperatively and is followed by a follow-up visits at 2 and 6 weeks, 3, 6, 12 months, and 5, 10 years after the intervention. Unveiling of the allocation is at 12 months post-intervention.